Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Evonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine

Filed Under: Pharma Tagged With: , , , ,

Evonik Industries AG supplies lipids essential to production of the Pfizer–BioNTech COVID-19 vaccine, in which messenger RNA (mRNA) is enclosed…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Japan Looks to Catch the West as Opportunities Open up for mRNA Pharmaceuticals
Japan Looks to Catch the West as Opportunities Open up for…
NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
Taiwan Looks to Establish CDMOs for mRNA Technology
Taiwan Looks to Establish CDMOs for mRNA Technology
Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines
Coronavirus Report – Part 58: Clinical Trials Begin for Slew…
Just How Effective Will Vaccines Be in Combating the COVID-19 Pandemic?
Just How Effective Will Vaccines Be in Combating the…
Spate of Japanese-Developed COVID-19 Vaccines Head Into Later Stages of Development, Clinical Trials
Spate of Japanese-Developed COVID-19 Vaccines Head Into…